Cargando…
Mitosis in circulating tumor cells stratifies highly aggressive breast carcinomas
BACKGROUND: Enumeration of circulating tumor cells (CTCs) isolated from the peripheral blood of breast cancer patients holds promise as a clinically relevant, minimally invasive diagnostic test. However, CTC utility has been limited as a prognostic indicator of survival by the inability to stratify...
Autores principales: | Adams, Daniel L., Adams, Diane K., Stefansson, Steingrimur, Haudenschild, Christian, Martin, Stuart S., Charpentier, Monica, Chumsri, Saranya, Cristofanilli, Massimo, Tang, Cha-Mei, Alpaugh, R. Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855427/ https://www.ncbi.nlm.nih.gov/pubmed/27142282 http://dx.doi.org/10.1186/s13058-016-0706-4 |
Ejemplares similares
-
Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining
por: Adams, Daniel L, et al.
Publicado: (2016) -
CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome
por: Raghavakaimal, Ashvathi, et al.
Publicado: (2022) -
Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer
por: Gardner, Kirby P., et al.
Publicado: (2022) -
A cell transportation solution that preserves live circulating tumor cells in patient blood samples
por: Stefansson, Steingrimur, et al.
Publicado: (2016) -
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
por: Fernandez, Sandra V, et al.
Publicado: (2014)